Home › Funds › Principal Global Investors › ABUS
Principal Global Investors position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)12.30K sh
Reported value held$59.03K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 11.84K | $32.00K | New |
| Q3 2022 | 14.03K | $27.00K | Add |
| Q4 2022 | 38.83K | $90.48K | Add |
| Q1 2023 | 39.08K | $118.42K | Add |
| Q2 2023 | 41.69K | $95.88K | Add |
| Q3 2023 | 45.60K | $92.57K | Add |
| Q4 2023 | 45.58K | $113.94K | Hold |
| Q1 2024 | 41.45K | $106.94K | Reduce |
| Q2 2024 | 26.11K | $80.67K | Reduce |
| Q3 2024 | 13.76K | $52.96K | Reduce |
| Q4 2024 | 12.82K | $41.91K | Reduce |
| Q1 2025 | 11.53K | $40.23K | Reduce |
| Q2 2025 | 10.81K | $33.40K | Reduce |
| Q3 2025 | 11.86K | $53.84K | Add |
| Q1 2026 | 10.98K | $49.40K | New |
| Q2 2026 | 12.30K | $59.03K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026